Diagnostics & Research Stocks
Recent market-moving SEC filings and news across diagnostics & research companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a diagnostics & research company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Biotech StocksMedical Device StocksPharmaceutical StocksHealth Tech StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
Quantum Cyber Says Short-Seller Offered to Silence Reports in Exchange for Dropping $5.69M Lawsuit
Prenetics Signs Lily Collins as IM8 Global Ambassador and Shareholder
bioAffinity Technologies Executes 1-for-15 Reverse Split to Regain Nasdaq Compliance
BioAffinity Announces 1-for-15 Reverse Split to Regain Nasdaq Compliance
ProPhase Labs Q2 2026: $3.05M Loss, $20K Cash, Going Concern Doubt Persists
Scorpion Capital Shorts Twist Bioscience, Calls AI Drug Story a 'Speculative Delusion'
Anthropic Taps Twist Bioscience to Validate Claude's Drug Design, Stock Surges 17%
bioAffinity Inks Federal Distribution Deal for CyPath Lung with AvMEDICAL
Prenetics Q2 Revenue Soars 288% YoY, Raises FY26 Guidance, Achieves First Positive Adjusted FCF
Prenetics Initiates 2027 IM8 Revenue Guidance at $400M+
CEO Michael Petras Files to Sell $21.6M in Sotera Health Shares
ENDRA Reports Surprise Q2 Profit on Digital Asset Gains, Merger on Track
Digital asset gains drive ENDRA to Q2 profit; merger closing expected in Q4
Check-Cap Prices $12.5M Offering at $8.72, Funding MBody AI Merger
Check-Cap Sets $12.5M Offering Terms at $8.72/Share to Fund MBody AI Merger
Trinovium Partners with Echelon Data Centres to Develop AI Liquid Cooling
Trinovium Partners with Echelon Data Centres on AI Liquid Cooling
ENDRA Swings to Q2 Profit on Digital Asset Gains, Merger on Track
bioAffinity Technologies Closes $4M Private Placement with Warrants
OPKO Health Taps Royalty Streams for $125M Senior Secured Notes
XWELL Flags Five Material Weaknesses and Q2 Loss as $13M Asset Sale Vote Looms
ENDRA Reports Q2 Profit on Digital Asset Gains, Regains Nasdaq Compliance
Precipio Q2 Revenue Jumps 24% but Going Concern Doubt Persists
Precipio Q2 Revenue Hits $7M, Up Sharply From Prior Year
Bleichroeder LP Discloses 33.2% Stake in MDxHealth After $20M Offering
MDxHealth Shares Surge 127% as CEO Sees Return to Positive EBITDA
bioAffinity Closes $4M At-the-Market Private Placement Amid Nasdaq Delisting Fight
Trinity Biotech Secures $7M from Perceptive, Regains Nasdaq Compliance
Trinity Biotech Lands $7M From Perceptive, Regains Nasdaq Compliance
Quantum Cyber Flags Going Concern Doubt, Material Weakness, and $16.1M Loss
MDxHealth Raises $20M in Registered Direct Offering at $0.454/Share
MDxHealth Q2 Revenue Up 16% to $27.2M; $20M Direct Placement at $0.454
bioAffinity Prices $4M At-the-Market Private Placement, Adding 8.5M Shares
Sera Prognostics Q2 Revenue Rises on Medicaid Mandate and New Partnerships
Sera Prognostics Q2 2026: Revenue Climbs 76% YoY, Cash Runway Extended to 2029
Neuronetics Q2 Revenue Beats, But Going Concern Warning Clouds Outlook
Waters Q2 2026: Revenue Doubles on BDS Deal, but Heavy Amortization and Restructuring Drive Net Loss
Revvity Q2 2026: 1% Revenue Growth, $46M Restructuring, and China Immunodiagnostics Divestiture
Check-Cap Sets Reverse Split for Aug 13, Merger on Track for Q3 Close
Neuronetics Beats Q2 Revenue, Narrows Loss, and Lifts Margin Outlook